Abbott to develop Scios heart hormone test:
This article was originally published in Clinica
Executive Summary
Abbott Laboratories is developing a heart failure test based on the hormone b-type natriuetic peptide. Abbott has signed a semi-exclusive licence with Scios, a Californian biopharmaceutical company, to develop automated tests for raised levels of the cardiac hormone.